These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 2316510

  • 1. Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets.
    Nishio K, Fujimura Y, Niinomi K, Takahashi Y, Yoshioka A, Fukui H, Usami Y, Titani K, Ruggeri ZM, Zimmerman TS.
    Am J Hematol; 1990 Apr; 33(4):261-6. PubMed ID: 2316510
    [Abstract] [Full Text] [Related]

  • 2. The von willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728.
    Fujimura Y, Holland LZ, Ruggeri ZM, Zimmerman TS.
    Blood; 1987 Oct; 70(4):985-8. PubMed ID: 3498523
    [Abstract] [Full Text] [Related]

  • 3. Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination.
    Matsui T, Hori A, Hamako J, Matsushita F, Ozeki Y, Sakurai Y, Hayakawa M, Matsumoto M, Fujimura Y.
    J Thromb Haemost; 2017 Mar; 15(3):538-548. PubMed ID: 28071872
    [Abstract] [Full Text] [Related]

  • 4. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D.
    Thromb Haemost; 1990 Oct 22; 64(2):326-32. PubMed ID: 1702906
    [Abstract] [Full Text] [Related]

  • 5. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
    Andrews RK, Booth WJ, Gorman JJ, Castaldi PA, Berndt MC.
    Biochemistry; 1989 Oct 17; 28(21):8317-26. PubMed ID: 2557900
    [Abstract] [Full Text] [Related]

  • 6. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
    Matsushita T, Sadler JE.
    J Biol Chem; 1995 Jun 02; 270(22):13406-14. PubMed ID: 7539426
    [Abstract] [Full Text] [Related]

  • 7. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
    Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK.
    Biochemistry; 1992 Nov 17; 31(45):11144-51. PubMed ID: 1359905
    [Abstract] [Full Text] [Related]

  • 8. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
    Obert B, Houllier A, Meyer D, Girma JP.
    Blood; 1999 Mar 15; 93(6):1959-68. PubMed ID: 10068669
    [Abstract] [Full Text] [Related]

  • 9. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein Ib and von Willebrand factor.
    Ozaki Y, Satoh K, Yatomi Y, Miura S, Fujimura Y, Kume S.
    Biochim Biophys Acta; 1995 Apr 13; 1243(3):482-8. PubMed ID: 7537105
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Alboaggregin-B and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on von Willebrand factor binding to platelets.
    Yoshida E, Fujimura Y, Miura S, Sugimoto M, Fukui H, Narita N, Usami Y, Suzuki M, Titani K.
    Biochem Biophys Res Commun; 1993 Mar 31; 191(3):1386-92. PubMed ID: 8466514
    [Abstract] [Full Text] [Related]

  • 13. von Willebrand factor mediates platelet spreading through glycoprotein Ib and alpha(IIb)beta3 in the presence of botrocetin and ristocetin, respectively.
    McCarty OJ, Calaminus SD, Berndt MC, Machesky LM, Watson SP.
    J Thromb Haemost; 2006 Jun 31; 4(6):1367-78. PubMed ID: 16706984
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
    Rabinowitz I, Tuley EA, Mancuso DJ, Randi AM, Firkin BG, Howard MA, Sadler JE.
    Proc Natl Acad Sci U S A; 1992 Oct 15; 89(20):9846-9. PubMed ID: 1409710
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
    De Marco L, Mazzuccato M, Grazia Del Ben M, Budde U, Federici AB, Girolami A, Ruggeri ZM.
    J Clin Invest; 1987 Aug 15; 80(2):475-82. PubMed ID: 3038958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.